Consequences of using poly-ether-ether-ketone versus traditional implant on tibial cement penetration and short-term clinical outcomes during total knee arthroplasty: a randomized controlled trial.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
09 Aug 2023
Historique:
received: 07 06 2023
accepted: 01 08 2023
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: epublish

Résumé

The use of poly-ether-ether-ketone (PEEK) prosthesis during total knee arthroplasty (TKA) is a relatively new concept. Several studies have suggested that the thickness of cement penetration during TKA may affect the stability of the implants. The present study aimed to compare the cement penetration and clinical performance between PEEK and traditional cobalt chromium molybdenum (CoCrMo) prosthesis during TKA. This study was a randomized controlled trial with level I of evidence. A total of 48 patients were randomly assigned to either the PEEK group (n = 24) or the CoCrMo group (n = 24). Mean bone cement penetration under the tibial baseplate was assessed radiographically in four zones in the anteroposterior view and two zones in the lateral view, in accordance with the Knee Society Scoring System. Furthermore, parameters such as the Knee Society Score (KSS), visual analogue scale (VAS) scores, complications and survivorship at 1 year postoperatively were also compared. According to the results of this study, the mean bone cement penetration exhibited no significant difference between PEEK and CoCrMo groups (2.49 ± 0.61 mm vs. 2.53 ± 0.68 mm, p = 0.85). Additionally, there were no remarkable differences in the KSS clinical score, functional score, and VAS score between the two groups. Moreover, complications and survivorship were also statistically compared between the groups and presented no significant differences. Based on the current findings, it can be concluded that PEEK implant present similar bone cement penetration, short-term clinical outcomes, and survivorship with traditional CoCrMo implant in TKA without added complications. Trial registration Chinese Clinical Trial Registry (ChiCTR2100047563).

Sections du résumé

BACKGROUND BACKGROUND
The use of poly-ether-ether-ketone (PEEK) prosthesis during total knee arthroplasty (TKA) is a relatively new concept. Several studies have suggested that the thickness of cement penetration during TKA may affect the stability of the implants. The present study aimed to compare the cement penetration and clinical performance between PEEK and traditional cobalt chromium molybdenum (CoCrMo) prosthesis during TKA.
METHODS METHODS
This study was a randomized controlled trial with level I of evidence. A total of 48 patients were randomly assigned to either the PEEK group (n = 24) or the CoCrMo group (n = 24). Mean bone cement penetration under the tibial baseplate was assessed radiographically in four zones in the anteroposterior view and two zones in the lateral view, in accordance with the Knee Society Scoring System. Furthermore, parameters such as the Knee Society Score (KSS), visual analogue scale (VAS) scores, complications and survivorship at 1 year postoperatively were also compared.
RESULTS RESULTS
According to the results of this study, the mean bone cement penetration exhibited no significant difference between PEEK and CoCrMo groups (2.49 ± 0.61 mm vs. 2.53 ± 0.68 mm, p = 0.85). Additionally, there were no remarkable differences in the KSS clinical score, functional score, and VAS score between the two groups. Moreover, complications and survivorship were also statistically compared between the groups and presented no significant differences.
CONCLUSIONS CONCLUSIONS
Based on the current findings, it can be concluded that PEEK implant present similar bone cement penetration, short-term clinical outcomes, and survivorship with traditional CoCrMo implant in TKA without added complications. Trial registration Chinese Clinical Trial Registry (ChiCTR2100047563).

Identifiants

pubmed: 37559133
doi: 10.1186/s13018-023-04064-1
pii: 10.1186/s13018-023-04064-1
pmc: PMC10410788
doi:

Substances chimiques

polyetheretherketone 31694-16-3
Ketones 0
Ether 0F5N573A2Y
Bone Cements 0
Ethyl Ethers 0
Ethers 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

589

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

J Orthop Res. 2013 Mar;31(3):485-92
pubmed: 23097319
J Prosthodont Res. 2016 Jan;60(1):12-9
pubmed: 26520679
Arthroplast Today. 2020 Dec 05;6(4):972-975
pubmed: 33385035
Clin Orthop Relat Res. 1998 Nov;(356):73-8
pubmed: 9917670
Bone Joint J. 2013 Mar;95-B(3):295-300
pubmed: 23450010
J Biomech. 2021 Mar 30;118:110270
pubmed: 33578052
Clin Med Insights Arthritis Musculoskelet Disord. 2015 Feb 23;8:33-45
pubmed: 25780341
J Orthop Res. 2020 Jul;38(7):1436-1444
pubmed: 32437026
Biomaterials. 1995 Mar;16(4):287-95
pubmed: 7772668
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Knee Surg Sports Traumatol Arthrosc. 2016 Jan;24(1):96-101
pubmed: 25248311
Bone Joint Res. 2022 Apr;11(4):229-238
pubmed: 35400170
Front Surg. 2022 Feb 14;9:809699
pubmed: 35237649
J Arthroplasty. 2006 Apr;21(3):353-7
pubmed: 16627142
Medicine (Baltimore). 2018 Jan;97(4):e9668
pubmed: 29369184
Biomaterials. 2008 Apr;29(11):1563-72
pubmed: 18199478
Biomaterials. 2009 Nov;30(33):6485-94
pubmed: 19733391
J Mater Sci Mater Med. 2009 Jan;20(1):163-70
pubmed: 18704647
Arthroplast Today. 2022 Sep 20;17:165-171
pubmed: 36164312
Artif Organs. 2018 Aug;42(8):E204-E214
pubmed: 29435992
Spine J. 2015 Jul 01;15(7):e1-3
pubmed: 25862511
Clin Orthop Relat Res. 1984 May;(185):155-64
pubmed: 6705374
Clin Orthop Relat Res. 2013 Jan;471(1):94-101
pubmed: 22790529
Materials (Basel). 2020 Jul 26;13(15):
pubmed: 32722599
J Arthroplasty. 2009 Apr;24(3):461-7
pubmed: 18534458
Arthroplasty. 2021 Aug 4;3(1):29
pubmed: 35236479
Clin Orthop Relat Res. 2003 Apr;(409):158-68
pubmed: 12671498
J Arthroplasty. 2000 Apr;15(3):360-7
pubmed: 10794233
J Bone Joint Surg Am. 1979 Mar;61(2):173-80
pubmed: 422602
J Orthop Surg (Hong Kong). 2017 Jan;25(1):2309499016684323
pubmed: 28139192
Clin Orthop Relat Res. 2016 Nov;474(11):2394-2404
pubmed: 27432420
Clin Orthop Relat Res. 1989 Nov;(248):9-12
pubmed: 2805502
Proc Inst Mech Eng H. 2016 Nov;230(11):1008-1015
pubmed: 27637723
J Biomed Mater Res A. 2015 Nov;103(11):3689-702
pubmed: 25856801
Knee Surg Sports Traumatol Arthrosc. 2019 Apr;27(4):1270-1279
pubmed: 30470851
J Mech Behav Biomed Mater. 2013 Jan;17:221-8
pubmed: 23127632
Acta Orthop Scand. 2002 Aug;73(4):409-15
pubmed: 12358114
J Bone Joint Surg Br. 2012 Aug;94(8):1009-15
pubmed: 22844039
Int J Ophthalmol. 2020 May 18;13(5):725-730
pubmed: 32420218

Auteurs

Guanghui Zhao (G)

Department of Joint Surgery, Honghui Hospital, Xi'An Jiaotong University, No.555 East Youyi Road, Xi'an, Shanxi, China.

Shuxin Yao (S)

Department of Joint Surgery, Honghui Hospital, Xi'An Jiaotong University, No.555 East Youyi Road, Xi'an, Shanxi, China.

Xiangxiang Sun (X)

Department of Joint Surgery, Honghui Hospital, Xi'An Jiaotong University, No.555 East Youyi Road, Xi'an, Shanxi, China.

Jianbing Ma (J)

Department of Joint Surgery, Honghui Hospital, Xi'An Jiaotong University, No.555 East Youyi Road, Xi'an, Shanxi, China.

Jianpeng Wang (J)

Department of Joint Surgery, Honghui Hospital, Xi'An Jiaotong University, No.555 East Youyi Road, Xi'an, Shanxi, China. 280771976@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH